Christopher L. Peatey

Author

QIMR Berghofer Medical Research Institute

Also Known As

Christopher L Peatey, Christopher L. Peatey, Christopher Peatey, Christopher L. Peatey

Publications

712

Citations

H-Index

Concepts

All Affiliations

QIMR Berghofer Medical Research Institute The University of Queensland Griffith University Commonwealth Scientific and Industrial Research Organisation Medicines for Malaria Venture

About

Christopher L. Peatey is an author at QIMR Berghofer Medical Research Institute specializing in immunology, medicine, and malaria.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	271
2	Immunology	4	4	271
3	Biochemistry	1	1	46
4	Cell Biology	1	1	23
5	Cellular Physiology	1	1	23

Christopher L. Peatey

Publications

705

Citations

H-Index

Page 1

	Year	Citations
Effect of Antimalarial Drugs on<i>Plasmodium falciparum</i>Gametocytes Christopher L. Peatey, Tina S. Skinner‐Adams, Matthew W. A. Dixon, The Journal of Infectious Diseases Sexual StageTransgenic Plasmodium FalciparumMedicineAntiparasitic AgentMalaria	2009	141
Mitochondrial Membrane Potential in a Small Subset of Artemisinin-Induced Dormant<i>Plasmodium falciparum</i>Parasites In Vitro Christopher L. Peatey, Marina Chavchich, Nanhua Chen, The Journal of Infectious Diseases	2015	80
Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes? Christopher L. Peatey, Didier Leroy, Donald L. Gardiner, Malaria Journal	2012	79
Piperaquine Monotherapy of Drug-Susceptible<i>Plasmodium falciparum</i>Infection Results in Rapid Clearance of Parasitemia but Is Followed by the Appearance of Gametocytemia Cielo Pasay, Rebecca J. Rockett, Silvana Sekuloski, The Journal of Infectious Diseases	2016	67
A high-throughput assay for the identification of drugs against late-stage Plasmodium falciparum gametocytes Christopher L. Peatey, Timothy Spicer, Peter Hodder, Molecular and Biochemical Parasitology Drug TargetAntiparasitic AgentMedicineBioanalysisMalaria	2011	61
The Aminopeptidase Inhibitor CHR-2863 Is an Orally Bioavailable Inhibitor of Murine Malaria Tina S. Skinner‐Adams, Christopher L. Peatey, Karen Anderson, Antimicrobial Agents and Chemotherapy Inhibitory ActivityM1 Alanine AminopeptidaseBiochemistryAntiparasitic AgentMedicine	2012	46
Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in Australia Rebecca Watts, Anand Odedra, Louise Marquart, PLoS Medicine	2020	45
Identifying the fitness costs of a pyrethroid-resistant genotype in the major arboviral vector Aedes aegypti Lisa Rigby, Gordana Rašić, Christopher L. Peatey, Parasites & Vectors	2020	35
Dormant <i>Plasmodium falciparum</i> Parasites in Human Infections Following Artesunate Therapy Christopher L. Peatey, Nanhua Chen, Karryn Gresty, The Journal of Infectious Diseases	2020	35
Antimalarial Asexual Stage-Specific and Gametocytocidal Activities of HIV Protease Inhibitors Christopher L. Peatey, Katherine T. Andrews, Nina Eickel, Antimicrobial Agents and Chemotherapy	2009	32

Page 1